Plain-English translation of NCT07574619 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a counseling approach called CUPID that helps couples in Uganda make informed choices about HIV prevention medication (PrEP, or pre-exposure prophylaxis). The program gives couples information about their prevention options, encourages them to talk together about what matters to them, and supports them in choosing the option that fits their lives best. Researchers want to see whether this couples-based approach helps more women start and stick with their chosen HIV prevention method.
Many women in Uganda want access to HIV prevention medication, but they may not have enough information to choose the best option for their situation, and they may not have their partner's support in using it. This study exists to see whether counseling that includes both partners can help women make better choices and actually use their chosen prevention method consistently.
You likely qualify if…
You likely don't qualify if…
If you join this study, you and your partner would attend counseling sessions where staff help you discuss and decide together on an HIV prevention method that works for your relationship and life. You would attend follow-up visits at your health facility to receive your chosen medication and discuss how it's working for you. The study takes place at health clinics in Uganda and lasts as long as you continue receiving HIV prevention care, with periodic check-ins to see how you're doing.
AI-generated summary from trial data · Aug 7, 2026 · Not medical advice
Uganda